Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Chongqing Huapont to Raise $146 Million in Private Placement

publication date: Mar 26, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
 Chongqing Huapont Pharmaceutical announced it will raise 920 million RMB ($146 million) in a private placement. The company said it will spend the proceeds on four projects: 300 million RMB ($47.5 million) on a new R&D center; 280 million RMB ($44.3 million) to increase production capacity; 210 million RMB on a topical formulation facility ($33.3 million), leaving 120 million ($19 million) for general corporate use. The company will issue 25 million shares at 32.99 RMB each. More details....

Stock Symbol:  (SHE: 002004)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China

>>More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners